Ketamine in Europe
Objective: This webinar aims to provide insights into the European ketamine market and will expand on health-related harms caused by non-medical ketamine use.
Objective: This webinar aims to provide insights into the European ketamine market and will expand on health-related harms caused by non-medical ketamine use.
Join us for the launch of the European Drug Report 2026: Trends and Developments on 9 June 2026. The report delivers the latest evidence on the state of the drugs problem in Europe.
Time: 09:00 WEST (Lisbon), 10:00 CEST (Brussels) (NB time to be confirmed)
Objective: Taking place on the eve of International Drug Checking Day, this webinar offers a timely opportunity to highlight the role drug-checking services play across three domains: harm reduction, drug market monitoring and public health alerts. The session will demonstrate the benefits of drug checking for a variety of stakeholders, including consumers, public health authorities and monitoring bodies.
The Addiction Health Services Research (AHSR) conference brings together researchers, policymakers, and treatment providers to solve the problems of inequity, access, effectiveness, and implementation of addiction services.
Clarion Congress Hotel Prague, Czech Republic
If you’re working to improve the health or rights of people who use drugs, INHSU 2026 is a must-attend event. A vibrant space where research, practice, policy, and lived experience come together on equal footing.
Date: Thursday 19th March, 2026
Time: 14:30 - 15:30 CEST Brussels local time
In December 2025, the European Union adopted a new drugs strategy. What are the priorities? What's new? How might this affect in practice? Its coordinator, Jo De Cock, will present it and answer questions from representatives of civil society and academia.
Introductory words: